Press Information
Press Releases
ATTD Press Releases
A record number of experts on diabetes technology and treatment came together in Barcelona and online for the 15th ATTD Conference
The 15th anniversary of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022), brought together a record number of experts in the field of diabetes treatment and technology in Barcelona and online. Over 4200 experts and practitioners from 100 countries discussed the most cutting-age technologies and scientific discoveries.
“We were extremely happy to meet with the ATTD community in-person again. We are sure that these interactions will speed up the process from doing research and discussing ideas to creating products and new technologies that people with diabetes could use in their daily lives”, Founders and Conference Chairmen Prof. Moshe Phillip and Prof. Tadej Battelino shared during the first ATTD Press Conference.
“15 years ago we didn’t even dream that this Conference will be so successful. In our first ATTD events, we talked about automatic insulin delivery systems, known as artificial pancreas. Back then it we looked at it as if it is a science fiction. Over the years we did a lot to push the field forward”, Prof. Phillip says on the occasion of the 15th year anniversary of the Conference.
“ATTD started very humbly with a simple mission – to bring together all stakeholders in diabetes”, Prof. Battelino adds. He explains that what makes ATTD a unique conference, is that it does not only include diabetologists, nurse educators, dieticians, psychologists and social workers. It particularly focuses on those that develop new technologies such as engineers and pharmacies, as well as those who produce and market them – big international corporations and those that enable people to get them – the insurance systems and people, who do clinical research. Finally, the conference also invites patients – those who can select what the best solution for controlling diabetes is.
“Throughout these 15 years the mission remained the same. We see that more and more people come to exchange opinions and advance ideas and I believe that these meetings have significantly accelerated the translation of new discoveries into what people with diabetes use in their everyday lives”, the Prof. Battelino concludes.
The 4-day scientific program included diverse topics including updates on COVID-19 and diabetes, artificial intelligence, telehealth, personalized medicine in diabetes, brain & diabetes, and of course, diabetes technology and innovations.
“Every year the quality of the ATTD gathering is just profound. It keeps getting stronger and stronger. As a patient myself, I know that those of us who have access to good doctors are very lucky because we can see all the holistic parts of diabetes health… We must make sure that we use the very best learnings in the world and that we are working arm in arm with the health economists who can help point out what the best interventions are”, Kelly L. Close, Founder and Chair of the Board of the diaTribe Foundation President and Founder of Close Concerns shared in the press conference.
The press conference will be available on-demand on the ATTD virtual platform for up to 3 months after the end of ATTD 2022.
Awards
On the final day of the Conference, the 2022 ATTD Insulin Centennial Award was awarded to Prof. Stephanie Amiel. Prof. Amiel was recognized for the value and importance of continued innovation in diabetes, and award an exemplary individual for their work within diabetes innovation.
ATTD Yearbook
The ATTD conference also marked the publication of the 2021 ATTD Yearbook, which includes some of the most important peer‐reviewed manuscripts published in medical journals between July 1, 2020, and June 30, 2021. The book summarizes the key innovations in the treatment of diabetes in the last year.
The Yearbook includes an article entitled “COVID‐19 Pandemic and Diabetes Care,” where the role of telehealth in managing diabetes is discussed. Other articles deal with the advancement of the digital health technologies, with automated artificial intelligence–based decision support systems (advisors), continuous and intermittent glucose monitoring, digital/virtual diabetes clinics, and virtual training and education.
While the focus of the Yearbook is on technology and related topics, it also covers therapeutic areas, including the new insulins and insulin therapy, new medications for the treatment of diabetes.
The content of the ATTD 2021 Yearbook is free and available online here.
About ATTD
The International Conference on Advanced Technologies and Treatments of Diabetes (ATTD) was established in 2008 to connect clinicians, scientists, engineers, medical corporations, investors, start-ups, regulators, and individuals with diabetes to facilitate the development and implementation of novel diabetes technologies, medications, and integrated treatment solutions. Distinguished international professionals discuss and disseminate information on the latest technologies and treatments in our field.
The main focus of speeding up the translational process from clinical development to the usage in the routine clinical practice remained the same throughout the 15 years.
Contact
Simona Milenkova
PR Liaison & Social Media Team Lead
The 15th International Conference on Advanced Technologies & Treatments for Diabetes brings together the world’s leading experts on diabetes technology and treatment.
The 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022), the leading conference on developments in diabetes treatments and technology, is taking place on 27-30 April with over 4100 international participants from 100 countries, attending the Conference virtually and in Barcelona.
ATTD is celebrating 15 years of meetings, in which the Conference has grown out to be the premium platform for experts and practitioners in diabetes to showcase the most cutting-edge innovations and scientific developments in the field.
Founders and Conference Chairs, Prof. Moshe Phillip and Prof. Tadej Battelino, set out to create a community striving to change the lives of diabetes patients and have come a long way since the meeting initiated in 2008.
As always, the conference program focuses on the latest research data, which is fueled by a record number of 713 abstract submissions this year.
“We are very happy to be able to meet face-to-face again after two years. ATTD is constantly working on providing the platform for all professionals to share their work and knowledge.”
The rest of the 4-day scientific program covers diverse topics including updates on COVID-19 and diabetes, artificial intelligence and personalized medicine in diabetes, brain & diabetes, and of course, diabetes technology. The lineup of industry supported symposia tailors to those interested in updates about medical devices and strategies to improve the life of patients with diabetes using the latest technology.
Awards
During the closing ceremony, the 2022 Insulin Centennial Award will be awarded. This new initiative aims to recognize the value and importance of continued innovation in diabetes, and award an exemplary individual for their work within diabetes innovation.
At the same time, the chairmen of ATTD have also gotten special recognition this year, as they were selected to receive the first Children with Diabetes President’s Award for Innovation. The award is presented to the healthcare professional(s) that exemplifies extraordinary leadership in using innovation and advancements in technology for insulin delivery devices that help people with diabetes live a more normal life.
International Fair of New Technologies in Diabetes
Twenty-four start-ups and emerging companies will showcase the latest technological innovations and developments in diabetes treatment and management at the ATTD 2022 International Fair of New Technologies. Joining them are several promising startups that were awarded ATTD Start-Up Grants. Grant awardees include companies working to prevent diabetic blindness, develop wearables that monitor blood sugar, and improve insulin patch pumps.
“ATTD as a scientific platform has been providing the stage to startups in the diabetes field, which has been leading to breakthrough developments and innovations in the treatment of diabetes.”
ATTD Yearbook
The ATTD conference also marks the publication of the 2021 ATTD Yearbook, which summarizes the key innovations in the treatment of diabetes in the last year, providing an overview of the most relevant published data in the past year for easy reference by clinicians. The Yearbook will be available on the Conference website. The Yearbook is presented in an eagerly awaited Yearbook session on Friday, 29 April 2022 at 13:00 CEST.
Press Conference
On the second day of the conference, 28 April 2022, we will be holding a press conference to mark the 15th anniversary of the ATTD Conference. Speaking at the press conference will be Chairpersons, Profs. Moshe Phillip and Tadej Battelino, as well as Kelly L. Close, Founder and Chair of the Board of the diaTribe Foundation President and Founder of Close Concerns. They will highlight some of the most exciting scientific findings presented at the event and will announce the winning presentations of The International Fair of New Technologies in Diabetes.
Date: Thursday, 28 April 2022
Time: 10:30 – 11:30 CEST
Venue: Hall 118 & Online
The press conference will be streamed live on the ATTD congress platform and will be available on-demand in the weeks following the Conference.
About ATTD
The International Conference on Advanced Technologies and Treatments of Diabetes (ATTD) was established in 2008 to connect clinicians, scientists, engineers, medical corporations, investors, start-ups, regulators, and individuals with diabetes to facilitate the development and implementation of novel diabetes technologies, medications, and integrated treatment solutions. Distinguished international professionals discuss and disseminate information on the latest technologies and treatments in our field.
The main focus of speeding up the translational process from clinical development to the usage in the routine clinical practice remained the same throughout the 15 years.
Contact
Simona Milenkova
PR Liaison & Social Media Team Lead
The 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) is happening in less than two weeks. More than XX experts from around the globe will gather at 15th celebration of ATTD Conferences on 27-30 April 2022, in Barcelona & Online.
For 15 years we’ve been working on creating a global community that strives to move the diabetes field forward. Our gatherings have provided the stage for some of the most remarkable innovations in diabetes technology & treatment and we warmly welcome you to participate and celebrate the advancement together.
Press Conference
Conference Chairpersons Prof. Tadej Battelino and Prof. Moshe Phillip and Kelly L. Close, founder and Chair of the Board of The diaTribe Foundation President and Founder, Close Concerns.
Media representatives are cordially invited to participate in our press conference free of charge after accreditation.
Date: Thursday, 28 April 2022
Time: 10:30 CET – 11:00 CET
Venue: onsite in Barcelona and online in the virtual conference platform
The planned virtual press conference will provide the opportunity of live interaction with the experts and will be available on-demand in the weeks following the Conference.
, the scientific sessions and the expert interviews can be visited online or accessed in the weeks following the congress.
Scientific Program
Registration
Details about press registration can be found on our website, or, you can contact our registration department directly via reg_attd22@kenes.com to arrange your complimentary registration. You can attend ATTD in-person, or as a virtual participant.
More information about the Conference and the novelties at this year’s program can be found here.
If you have any questions in the meantime, feel free to reach out to our PR Liaison, Simona Milenkova, via smilenkova@kenes.com
With kind regards,
Simona Milenkova
PR Liaison & Social Media Team Lead
Other Press Releases
Insulcloud, an Innovative SME certified company that has developed the world’s first device that improves the quality of life of people with diabetes and their families, thanks to the real-time monitoring of the use of disposable insulin pens, has closed a financing round of 4 million euros.
The financing round was led by one of the world’s leading diabetes companies, as well as a key player for the company’s goals. This milestone is a great boost for the Spanish company’s 360 technology, as it facilitates its goal of providing, in real time, all the fundamental information needed for the daily control of people with diabetes. For example, blood glucose levels, insulin injected, physical activity or intake, which is automatically provided to each patient’s medical record.
Insulcloud was the first company in the world to develop a device compatible with disposable insulin pens to monitor their use and avoid potential risks. In addition, the company has launched a platform that allows different Health Management Systems to monitor patients with diabetes in real time.
“We are creating a future,” says José Luis López, CEO and founder of the company, “in which all relevant data on diabetes monitoring and control are directly and automatically stored in the patient’s own medical records. Technologically this is already possible and now is the time to push it forward”.
Press Registration
We hereby would like to invite you to attend the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022), which takes place from 27-30 April 2022, in Barcelona & Online.
We’re celebrating 15 years of ATTD Conferences, and thereby, 15 years of gatherings where innovation in diabetes technology & treatment are the core focus. During this time, we’ve been working on creating a global community that strives to moves the diabetes field forward.
We warmly welcome you to participate and join the advancement.
We offer complimentary registration for members of the press. However, press credentials are required.
To register, please send us valid press ID card or a letter from the publisher of the institution/journal you are working for by email to: reg_attd22@kenes.com Please, make sure you specify your full name and address.
Press Conference
On the second day of the conference, 28 April 2022, we will be holding a press conference to mark the 15th anniversary of the ATTD Conference. Speaking at the press conference will be Chairpersons, Profs. Tadej Battelino and Moshe Phillip, as well as Kelly L. Close, Founder, and Chair of the Board of the diaTribe Foundation President and Founder of Close Concerns. They will highlight some of the most exciting scientific findings presented at the event and will announce the winning presentations of The International Fair of New Technologies in Diabetes.
Date: Thursday, 28 April 2022
Time: 10:30 – 11:30 CEST
Venue: Hall 118 & Online
The press conference will be streamed live on the ATTD congress platform and will be available on-demand in the weeks following the Conference.
Embargo Policy
We produce and distribute press releases summarizing upcoming content that will be presented at ATTD 2022. Parts of the content in the press releases, which refer to industry news and presented scientific papers, will be embargoed until the time and date clearly stated on the press release.
Our policy is to release information about the content presented at ATTD 2022 in a way that provides fair and equal access to all media representatives, allowing them to understand the most up-to-date version of the scientific findings that are to be presented. Media representatives and their institutions’ press offices are encouraged to interact with the ATTD 2022 Press Liaison ahead of publication, and benefit from the subsequent coverage.
Scientific Research
- The oral presentation abstracts and invited speaker abstracts are already available online in the program.
- Abstracts will be available in the Diabetes Technology & Therapeutics Journal as soon as the ATTD 2022 Conference starts on 27 April 2022.
- The ePoster abstracts will also be available on the official ATTD Conference app, the virtual platform and onsite as soon as the ATTD 2022 Conference starts on 27 April 2022. In addition, the ePoster presenters have been offered to submit audio files, which will only be available on the virtual conference platform.
Photography and videography
Photography and videography are permitted at the ATTD 2022 Event only for registered media representatives. You are authorized to collect video material as follows:
- In the lobby, exhibition area and all common spaces outside the session halls.
- In the session halls, during the first 5 minutes of any session from the front of the room unless you are specifically asked NOT to film by the speaker/chair/company representative.
- After 5 minutes, no flash photography will be allowed, and cameras will need to be removed from the front of the room.
- If you are staying after the first 5 minutes, you must have a seat in the audience.
Interviews are allowed
Onsite interviews are allowed. However, the ATTD organizers cannot assist with the arrangements. As part of the authorization, we request you reference the content collected at ATTD 2022 and share it with us after it is published.
Questions/Inquiries?
Do you have any press-related questions? For any inquiries, please contact our PR Liaison – Simona Milenkova.
